I recall that years ago, well before Top Line Data was published, it was discussed in this forum that NWBO was already in talks with NICE. I cannot believe that for all this time Management has been sitting on its collective backside since then having no further contact with NICE to agree a mutually acceptable price for immediate application when NWBO receives the OK from the MHRA.
I would hope that when the MHRA announces its blessing, at the same time NICE will announces that they and NorthWest Biotherapeutics have agreed a price for DCVax-L and that it has been accepted into the armamentarium of the NHS with immediate effect.
A double whammy.
Market Data 
Markets 
AI
